http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108855031-B

Outgoing Links

Predicate Object
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C02F2305-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C02F2101-306
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C02F2101-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C02F2101-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C02F2101-34
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B01J35-004
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B01J35-023
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C02F1-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B01J23-04
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C02F1-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/B01J23-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/B01J35-02
filingDate 2018-07-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2021-06-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2021-06-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-108855031-B
titleOfInvention Nanotube material suitable for kasugamycin wastewater treatment and preparation method thereof
abstract The invention relates to a nanotube material suitable for kasugamycin wastewater treatment and a preparation method thereof, wherein the nanotube material comprises Na 2 O‑Al 2 O 3 ‑SiO 2 ‑TiO 2 . The novel nanotube material provided by the invention can well remove COD and ammonia nitrogen in kasugamycin wastewater, is efficient, safe and environment-friendly, and is beneficial to treatment of the kasugamycin wastewater. In addition, the novel nanotube material can well treat the kasugamycin wastewater treated by biological combined membranization, and the wastewater treated by the nanotube reaches the national relevant antibiotic wastewater discharge standard.
priorityDate 2018-07-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105709716-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450313723
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450570636
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449993433
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24544
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID161126698
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448315045
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57369825
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9855836
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454377287
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID26053
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419529873
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24182
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6857397
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID65174
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24502
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448525486
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24863
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453072635
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419498977
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID162021770
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410509432
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID13011288
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449704143
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410440450
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11043
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453136209

Total number of triples: 47.